CD19 and acute lymphoblastic leukemia: The abnormal cell population showed the following immunophenotype, which was consistent with pre-B-ALL (FAB classifications): CD45+, HLADr+, CD117+, CD34+, CD19+, CD10+, CD38+ and expressed CD123 and CD11c (52%) heterogeneously.